journal article·2020-10-28

Zebrafish: A Promising Model for Evaluating the Toxicity of Carbon Dot-Based Nanomaterials

Wei Liu, Gang Huang, Xiaoying Su, Siyi Li, Qun Wang, Yuying Zhao, Yao Liu, Jingshan Luo, Ye Li, Chuwen Li, Dongsheng Yuan, Honghai Hong, Xiaojia Chen, Tongkai Chen

ACS Applied Materials & Interfaces· Volume 12· Issue 43
Publisher page

Abstract

Carbon dots (CDs) exhibit a wide range of desirable properties including excellent photoluminescence, photostability, and water solubility, making them ideally suitable for use in the context of drug delivery, bioimaging, and related biomedical applications. Before these CDs can be translated for use in humans, however, further research regarding their in vivo toxicity is required. Owing to their low cost, rapid growth, and significant homology to humans, zebrafish (Danio rerio) are commonly employed as in vivo model systems in the toxicity studies of nanomaterials. In the present report, our group employed a hydrothermal approach to synthesize CDs and then assessed their toxicity in zebrafish. The resultant CDs were roughly 2.4 nm spheroid particles that emitted strong blue fluorescence in response to the excitation at 365 nm. These CDs did not induce any evident embryonic toxicity or did cause any apparent teratogenic effects during hatching or development when dosed at 150 μg/mL. However, significant effects were observed in zebrafish embryos at CD concentrations >200 μg/mL, including pericardial and yolk sac edema, delayed growth, spinal cord flexure, and death. These high CD concentrations were further associated with the reduction in zebrafish larval locomotor activity and decreased dopamine levels, reduced frequencies of tyrosine hydroxylase-positive dopaminergic neurons, and multiple organ damage. Further studies will be required to fully understand the mechanistic basis for CD-mediated neurotoxicity, with such studies being essential to fully understand the translational potential of these unique nanomaterials.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China

State Key Laboratory of Non-Food Biomass and Enzyme Technology, Guangxi Academy of Sciences, Nanning 530007, China

School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou 511400, China

Department of Pharmacy, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China

School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China

Department of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China

Funding

Universidade de Macau · Natural Science Foundation of Guangdong Province · Guangdong Province

References (40)

Show source-provided references
1. 10.1021/acs.langmuir.9b0061110.1021/acs.langmuir.9b00611 ↗
2. 10.1039/C8NR10091H10.1039/C8NR10091H ↗
3. 10.1016/j.drudis.2019.01.01310.1016/j.drudis.2019.01.013 ↗
4. 10.1016/j.biomaterials.2016.06.02310.1016/j.biomaterials.2016.06.023 ↗
5. 10.2147/IJN.S18968810.2147/IJN.S189688 ↗
6. 10.1016/j.biomaterials.2018.12.02510.1016/j.biomaterials.2018.12.025 ↗
7. 10.1016/j.jcis.2017.09.00710.1016/j.jcis.2017.09.007 ↗
8. 10.1016/j.cclet.2019.01.01410.1016/j.cclet.2019.01.014 ↗
9. 10.1039/C8NR08970A10.1039/C8NR08970A ↗
10. 10.1021/acsami.7b1971610.1021/acsami.7b19716 ↗
11. 10.1016/j.biomaterials.2017.05.04010.1016/j.biomaterials.2017.05.040 ↗
12. 10.1016/j.colsurfb.2018.11.04110.1016/j.colsurfb.2018.11.041 ↗
13. 10.1021/nl203526f10.1021/nl203526f ↗
14. 10.1016/j.toxlet.2008.05.00610.1016/j.toxlet.2008.05.006 ↗
15. 10.1021/acsnano.8b0003610.1021/acsnano.8b00036 ↗
16. 10.1021/nn700048y10.1021/nn700048y ↗
17. 10.1007/s11356-019-05870-z10.1007/s11356-019-05870-z ↗
18. 10.1039/C7EN01239J10.1039/C7EN01239J ↗
19. 10.1016/j.mod.2004.10.00910.1016/j.mod.2004.10.009 ↗
20. 10.1242/dev.10031310.1242/dev.100313 ↗
21. 10.1371/journal.pone.011166410.1371/journal.pone.0111664 ↗
22. 10.1039/c3ra41503a10.1039/c3ra41503a ↗
23. 10.1016/j.brainresbull.2007.10.04310.1016/j.brainresbull.2007.10.043 ↗
24. 10.1039/C7RA09002A10.1039/C7RA09002A ↗
25. 10.1016/j.envres.2014.06.01710.1016/j.envres.2014.06.017 ↗
26. 10.1016/j.reprotox.2015.04.00110.1016/j.reprotox.2015.04.001 ↗
27. 10.1016/j.carbpol.2016.01.01210.1016/j.carbpol.2016.01.012 ↗
28. 10.1016/j.ntt.2010.03.00210.1016/j.ntt.2010.03.002 ↗
29. 10.1016/j.pbb.2019.17282810.1016/j.pbb.2019.172828 ↗
30. 10.1016/j.neuroscience.2017.10.01810.1016/j.neuroscience.2017.10.018 ↗
31. 10.1016/j.aquatox.2017.02.01710.1016/j.aquatox.2017.02.017 ↗
32. 10.1186/2050-6511-15-1510.1186/2050-6511-15-15 ↗
33. 10.1016/j.proche.2014.05.00610.1016/j.proche.2014.05.006 ↗
34. 10.1021/acsami.9b0007410.1021/acsami.9b00074 ↗
35. 10.1016/S0012-1606(02)00034-910.1016/S0012-1606(02)00034-9 ↗
36. 10.1016/j.ijpharm.2020.11905310.1016/j.ijpharm.2020.119053 ↗
37. 10.1038/nprot.2006.34210.1038/nprot.2006.342 ↗
38. 10.1016/j.envpol.2018.06.01310.1016/j.envpol.2018.06.013 ↗
39. 10.1038/srep1183510.1038/srep11835 ↗
40. 10.1021/acsnano.5b0458310.1021/acsnano.5b04583 ↗